Bioharvest grants options to buy 423,000 shares

BioHarvest Sciences Inc. has granted of a total of 423,000 stock options to employees and consultants. The stock options granted are exercisable to purchase a common share of the company at a price of 45 cents per share for a term of 10 years.

A total of 370,000 stock options granted will vest quarterly over a three-year period and 53,000 will vest monthly over a four-month period.

About Bioharvest Sciences Inc.

Based in Vancouver, B.C., Bioharvest Sciences is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The company’s technology is non-GMO (genetically modified organism) and has already been validated by Vinia, the red grapes cells functional food/dietary supplement produced and sold by Bioharvest Sciences. The company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with Vinia and other superfruit nutraceutical products. Further, by adapting this technology to the cannabis plant, and building adequate production capacity, Bioharvest’s objective is to also become a leading supplier of cannabis for both medicinal and legal recreational purposes.

We seek Safe Harbor.

Source

Click here to connect with BioHarvest Sciences (CSE:BHSC) for an Investor Presentation.